Hasegawa Takashi, Takahashi Kazunaga, Saijo Masaaki, Fukiwake Tomohide, Motoki Yuji
Chiba Prefectural Institute of Public Health, Japan.
Yakugaku Zasshi. 2013;133(1):7-11. doi: 10.1248/yakushi.12-00247-2.
Thirty-two psychotropic substances (31 compounds and one plant) have been controlled as designated substances (Shitei-yakubutsu) in Japan by the Pharmaceutical Affairs Law since April 2007. Although the trafficking of these drugs has decreased because of this regulation, new designer drugs (synthetic cannabinoids and cathinones) have appeared, one after the other. As of October 2011, 40 compounds had been newly added to this category. Analytical methods have become more complicated due to this increase in the number of designated substances. Moreover, many reference substances for such designated substances and other new designer drugs are not commercially available. For the reasons stated above, a lot of time and effort is required to analyze the illegal drug products available on the market.
自2007年4月起，根据日本《药事法》，32种精神药物（31种化合物和1种植物）被列为指定物质（指定薬物）。尽管由于这一规定，这些药物的贩运有所减少，但新的设计药物（合成大麻素和卡西酮）却相继出现。截至2011年10月，此类新增了40种化合物。由于指定物质数量的增加，分析方法变得更加复杂。此外，许多此类指定物质和其他新设计药物的参考物质在市场上无法买到。基于上述原因，分析市面上的非法药品需要耗费大量的时间和精力。
